NCT06903338Phase 3Active not recruiting

A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection

Study sponsor: Vir Biotechnology, Inc. · VIR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-30Actual
Enrollment · participants124Actual
Source updated2026-11-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Dec 2026. After: 30 Sep 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview